More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents
Clinical trial NCT03497676 · COMPLETED
Trial details
- NCT number
- NCT03497676
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2023-02-18
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.